Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.
作者信息
Miedema Michael D, Lopez Faye L, Blaha Michael J, Virani Salim S, Coresh Josef, Ballantyne Christie M, Folsom Aaron R
机构信息
Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.
出版信息
JAMA Intern Med. 2015 Jan;175(1):138-40. doi: 10.1001/jamainternmed.2014.6288.
Abstract
摘要
相似文献
1
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.
JAMA Intern Med. 2015 Jan;175(1):138-40. doi: 10.1001/jamainternmed.2014.6288.
2
American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
J Am Heart Assoc. 2017 May 11;6(5):e005045. doi: 10.1161/JAHA.116.005045.
3
Medicare-eligible patients diagnosed with atherosclerosis: patterns in statin therapy and lipid monitoring.
Curr Med Res Opin. 2009 Jun;25(6):1403-11. doi: 10.1185/03007990902905658.
4
Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
BMJ Open. 2017 Feb 17;7(2):e013255. doi: 10.1136/bmjopen-2016-013255.
5
Should you be taking a statin? A new guideline suggests that even adults with normal cholesterol numbers should be on the drug.
Johns Hopkins Med Lett Health After 50. 2014 Fall;26(9):1-4.
6
Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year.
J Manag Care Spec Pharm. 2016 Aug;22(8):901-8. doi: 10.18553/jmcp.2016.22.8.901.
7
Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
J Am Heart Assoc. 2017 Mar 17;6(3):e004909. doi: 10.1161/JAHA.116.004909.
8
Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).
Clin Cardiol. 2017 Mar;40(3):163-169. doi: 10.1002/clc.22642. Epub 2016 Nov 12.
9
Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
J Manag Care Spec Pharm. 2016 Aug;22(8):892-900. doi: 10.18553/jmcp.2016.22.8.892.
10
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Circulation. 2015 Sep 8;132(10):916-22. doi: 10.1161/CIRCULATIONAHA.115.016846. Epub 2015 Jul 29.
引用本文的文献
1
Are statins making older persons weaker? A discontinuation study of muscular side effects.
Geroscience. 2024 Feb;46(1):853-865. doi: 10.1007/s11357-023-00817-2. Epub 2023 May 25.
2
Primary prevention statin therapy in older adults.
Curr Opin Cardiol. 2023 Jan 1;38(1):11-20. doi: 10.1097/HCO.0000000000001003. Epub 2022 Nov 2.
3
Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis.
J Int Med Res. 2020 Jun;48(6):300060520926349. doi: 10.1177/0300060520926349.
4
Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system.
Clin Cardiol. 2020 Jun;43(6):560-567. doi: 10.1002/clc.23347. Epub 2020 Feb 27.
5
Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
J Am Heart Assoc. 2018 Jun 13;7(12):e008920. doi: 10.1161/JAHA.118.008920.
6
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.
J Am Coll Cardiol. 2018 Jan 23;71(3):292-302. doi: 10.1016/j.jacc.2017.11.007. Epub 2017 Nov 12.
7
Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.
J Am Heart Assoc. 2017 Apr 12;6(4):e005333. doi: 10.1161/JAHA.116.005333.
8
Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
JAMA Cardiol. 2017 Apr 1;2(4):361-369. doi: 10.1001/jamacardio.2016.5922.
9
Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines.
Mayo Clin Proc. 2015 Sep;90(9):1262-71. doi: 10.1016/j.mayocp.2015.05.018. Epub 2015 Aug 11.
10
Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.
Drugs Aging. 2015 Aug;32(8):649-61. doi: 10.1007/s40266-015-0290-9.
本文引用的文献
1
Application of new cholesterol guidelines to a population-based sample.
N Engl J Med. 2014 Apr 10;370(15):1422-31. doi: 10.1056/NEJMoa1315665. Epub 2014 Mar 19.
2
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
3
4
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.
Circulation. 2002 Aug 20;106(8):1024-8. doi: 10.1161/01.cir.0000032466.44170.44.
5
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.
Am J Epidemiol. 1989 Apr;129(4):687-702.
Zotero 插件